PLUTONIUM
246
9. REFERENCES
REAC/TS. 2010a. Package insert-instructions for use: Pantetate calcium trisodium injection. Radiation
Emergency Assistance Center/Training Site. Oak Ridge Institute for Science and Education. U.S.
Department of Energy. http://orise.orau.gov/files/reacts/Calcium-DTPA-package-insert.pdf. May 22,
2010.
REAC/TS. 2010b. Package insert-instructions for use: Pantetate zinc trisodium injection. Radiation
Emergency Assistance Center/Training Site. Oak Ridge Institute for Science and Education. U.S.
Department of Energy. http://orise.orau.gov/files/reacts/Zinc-DTPA-package-insert.pdf. May 22, 2010.
Robertson JB, Raju MR. 1980. Sudden reversion to normal radiosensitivity to the effects of x-irradiation
and plutonium-238 alpha particles by a radioresistant rat-mouse hybrid cell line. Radiat Res 83(1):197-
204.
Romanov SA, Guilmette RA, Hahn FF, et al. 2003. Modifying the ICRP 66 dosimetry model based on
results obtained from Mayak plutonium workers. Radiat Prot Dosimetry 105(1-4):85-90.
Rosenthal MW, Lindenbaum A, Russell JJ, et al. 1972a. Metabolism of monomeric and polymeric
plutonium in the rabbit; comparison with the mouse. Health Phys 23:231-238.
Rosenthal MW, Moretti E, Russell JJ, et al. 1972b. Marrow deposition and distribution of monomeric
and polymeric
239
Pu in the mouse, estimated by use of
59
Fe. Health Phys 22:743-748.
Rosenthal MW, Rahman YE, Moretti ES, et al. 1975. Removal of polymeric plutonium by DTPA
directed into cells by liposome encapsulation. Radiat Res 63:262-274.
Rubio Montero P, Martin Sanchez A. 2001. Plutonium contamination from accidental release or simply
fallout: study of soils at Palomares (Spain) J Environ Radioact 55:157-165.
Rundo J, Starzyk PM, Sedlet J, et al. 1976. The excretion rate and retention of plutonium 10,000 days
after acquistion. Diagnosis and treatment of incorporated radionuclides. Viema, Austriz: International
Atomic Energy, 15-23.
Russell JJ, Sikov MR, Kathren RL. 2003. Plutonium content of human placental tissues after
occupational exposure. Radiat Prot Dosimetry 104(3):231-236.
Sanchez AL, Walters CB, Singleton DL, et al. 1999. Food ingestion doses from artificial radionuclides
in Cumbrian diets, ten years post-Chernobyl. J Environ Radioact 46(3):301-317.
Sanders C. 1973. Carcinogenicity of inhaled plutonium-238 in the rat. Radiat Res 56:540-553.
*Sanders CL. 1975a. Effects of PuO
2
particles deposited in the lung following intraperitoneal injection.
Health Phys 28(1):84-86.
Sanders CL. 1975b. Dose distribution and neoplasia in the lung following intratracheal instillation of
239
PuO
2
and asbestos. Health Phys 28(4):383-386.
Sanders CL. 1977. Inhalation toxicology of
238
PuO
2
and
239
PuO
2
in Syrian golden hamsters. Radiat Res
70(2):334-344.
Sanders CL, Lundgren DL. 1995. Pulmonary carcinogenesis in the F344 and Wistar rat after inhalation
of plutonium dioxide. Radiat Res 144(2):206-214.
PLUTONIUM
247
9. REFERENCES
Sanders CL, Mahaffey JA. 1979. Carcinogenicity of inhaled air-oxidized plutonium-239 dioxide in rats.
Int J Radiat Biol Relat Stud Phys Chem Med 35(1):95-98.
Sanders CL, Mahaffey JA. 1983. Action of vitamin C on pulmonary carcinogenesis from inhaled
239
PuO
2
. Health Phys 45(3):794-798.
Sanders CL, Cannon WC, Powers GJ. 1978. Lung carcinogenesis induced by inhaled high-fired oxides
of beryllium and plutonium. Health Phys 35(2):193-199.
Sanders CL, Dagle GE, Cannon WC, et al. 1976. Inhalation carcinogenesis of high-fired
239
PuO
2
in rats.
Radiat Res 68(2):349-360.
Sanders CL, Dagle GE, Cannon WC, et al. 1977. Inhalation carcinogenesis of high-fired
238
PuO
2
in rats.
Radiat Res 71(3):528-546.
*Sanders CL, Lauhala KE, McDonald KE, et al. 1993a. Lifespan studies in rats exposed to
239
PuO
2
aerosol. (Erratum in: Health Phys 65(5):576). Health Phys 64(5):509-521.
Sanders CL, Lauhala KE, McDonald KE. 1993b. Lifespan studies in rats exposed to
239
PuO
2
aerosol.
III. Survival and lung tumours. Int J Radiat Biol 64(4):417-430.
Sanders CL, McDonald KE, Lauhala KE. 1988a. Promotion of pulmonary carcinogenesis by plutonium
particle aggregation following inhalation of
239
PuO
2
. Radiat Res 116(3):393-405.
Sanders CL, McDonald KE, Mahaffey JA. 1988b. Lung tumor response to inhaled Pu and its
implications for radiation protection. Health Phys 55(2):455-462.
Sato H, Takahashi S, Kubota Y. 2001. Effects of gadoinium on the retention and translocation of
239
Pu-
hydroxide. Health Phys 80(2):164-169.
Schofield GB. 1980. Biological control in a plutonium production facility. Br J Radiol 53(629):398-
409.
Schofield G, Howells H, Ward F, et al. 1974. Assessment and management of a plutonium contaminated
wound case. Health Phys 26:541-554.
Searle A, Beechey C, Green D, et al. 1976. Cytogenetic effects of protracted exposures to alpha-particles
from plutonium-239 and to gamma-rays from cobalt-60 compared in male mice. Mutat Res 41:297-310.
Searle A, Beechey C, Green D, et al. 1982. Dominant lethal and ovarian effects of plutonium-239 in
female mice. Int J Radiat Biol 42:235-244.
Sérandour AL, Tsapis N, Gervelas C, et al. 2007. Decorporation of plutonium by pulmonary
administration of Ca-DTPA dry powder: A study in rat after lung contamination with different plutonium
forms. Radiat Prot Dosimetry 127(1-4):472-476.
Setchell BP, Waites GMH. 1975. The blood-testis barrier. In: Creep RO, Astwood EB, Geiger SR, eds.
Handbook of physiology: Endocrinology V. Washington, DC: American Physiological Society, 143-
172.
Dostları ilə paylaş: |